PT Merck Tbk's latest marketcap:
As of 08/31/2026, PT Merck Tbk's market capitalization has reached $98.66 M. According to our data, PT Merck Tbk is the 26180th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 98.66 M |
| Revenue (ttm) | 76.27 M |
| Net Income (ttm) | 18.81 M |
| Shares Out | 448 M |
| EPS (ttm) | 0.04 |
| Forward PE | 0.00 |
| Ex-Dividend Date | 06/08/2026 |
| Earnings Date | 10/30/2026 |
PT Merck Tbk's yearly market capitalization.
| Date | Market Cap(Rp) | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 08/31/2026 | Rp1.75 T | $98.66 M | 4.48% | 26180 |
| 12/30/2025 | Rp1.5 T | $90.05 M | -6.94% | 23982 |
| 12/30/2024 | Rp1.61 T | $96.77 M | -13.88% | 23476 |
| 12/29/2023 | Rp1.87 T | $131.08 M | -12% | 21354 |
| 12/30/2022 | Rp2.13 T | $127.68 M | 28.73% | 20717 |
| 12/30/2021 | Rp1.65 T | $115.72 M | 12.5% | 22185 |
| 12/30/2020 | Rp1.47 T | $102.86 M | 15.09% | 20433 |
| 12/30/2019 | Rp1.28 T | $89.38 M | -33.72% | 18710 |
| 12/28/2018 | Rp1.93 T | $134.85 M | -49.41% | 15768 |
| 12/29/2017 | Rp3.81 T | $266.56 M | -7.61% | 13375 |
Company Profile
About PT Merck Tbk
PT Merck Tbk is a leading pharmaceutical company engaged in the manufacture and sale of healthcare products in Indonesia and internationally. Headquartered in Jakarta Timur, the company has been a key player in the industry since its founding in 1970.
Business Segments
- Biopharma – Focuses on prescription medicines for cardiovascular, metabolic, oncology, and neurodegenerative diseases.
- Consumer Health – Provides over-the-counter healthcare solutions for general wellness.
- Others – Includes office and property leasing and management activities.
Key Products & Research
The company develops and distributes pharmaceutical and biological treatments for:
- Colorectal and head & neck cancer
- Multiple sclerosis
- Infertility and growth hormone disorders
- Diabetes and thyroid conditions (e.g., hypothyroidism)
Corporate Background
Formerly known as PT Merck Indonesia Tbk, the company rebranded to PT Merck Tbk in June 2002. It operates as a subsidiary of Merck Holding GmbH.
Frequently Asked Questions
-
What is PT Merck Tbk's (IDX-MERK) current market cap?As of 08/31/2026, PT Merck Tbk (including the parent company, if applicable) has an estimated market capitalization of $98.66 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does PT Merck Tbk (IDX-MERK) rank globally by market cap?PT Merck Tbk global market capitalization ranking is approximately 26180 as of 08/31/2026. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.